Clinical Trials Browser

Phase 2 × NETWORK × Gonadotropin-Releasing Hormone × Clear all

NCT00528866 2019-04-24

Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy

Phase 2 Completed

80 enrolled 11 charts

Prostatic Neoplasms